|
1
|
Cohen S: Isolation of a mouse submaxillary
gland protein accelerating incisor eruption and eyelid opening in
the new-born animal. J Biol Chem. 237:1555–1562. 1962.PubMed/NCBI
|
|
2
|
Avraham R and Yarden Y: Feedback
regulation of EGFR signalling: Decision making by early and delayed
loops. Nat Rev Mol Cell Biol. 12:104–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burtness B, Bauman JE and Galloway T:
Novel targets in HPV-negative head and neck cancer: Overcoming
resistance to EGFR inhibition. Lancet Oncol. 14:e302-e3092013.
View Article : Google Scholar
|
|
4
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37(Suppl 4): S9–S15. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Selvaggi G, Novello S, Torri V, Leonardo
E, De Giuli P, Borasio P, Mossetti C, Ardissone F, Lausi P and
Scagliotti GV: Epidermal growth factor receptor overexpression
correlates with a poor prognosis in completely resected
non-small-cell lung cancer. Ann Oncol. 15:28–32. 2004. View Article : Google Scholar
|
|
6
|
Hirsch FR, Varella-Garcia M, Bunn PA Jr,
Di Maria MV, Veve R, Bremmes RM, Barón AE, Zeng C and Franklin WA:
Epidermal growth factor receptor in non-small-cell lung carcinomas:
Correlation between gene copy number and protein expression and
impact on prognosis. J Clin Oncol. 21:3798–3807. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonner JA, Harari PM, Giralt J, Azarnia N,
Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al:
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head
and neck. N Engl J Med. 354:567–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wheeler DL, Dunn EF and Harari PM:
Understanding resistance to EGFR inhibitors-impact on future
treatment strategies. Nat Rev Clin Oncol. 7:493–507. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
International Agency for Research on
Cancer (IARC): IARC Working Group on the Evaluation of Carcinogenic
Risks to Humans. Tobacco smoke and involuntary smoking. IARC Work
Gr Eval Carcinog Risks Hum. 83:1–1438. 2004.
|
|
11
|
Valavanidis A, Vlachogianni T and Fiotakis
K: Tobacco smoke: Involvement of reactive oxygen species and stable
free radicals in mechanisms of oxidative damage, carcinogenesis and
synergistic effects with other respirable particles. Int J Environ
Res Public Health. 6:445–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benowitz NL: Neurobiology of nicotine
addiction: Implications for smoking cessation treatment. Am J Med.
121(Suppl 1): S3–S10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanner T and Grimsrud TK: Nicotine:
Carcinogenicity and effects on response to cancer treatment - A
review. Front Oncol. 5:1962015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davis R, Rizwani W, Banerjee S, Kovacs M,
Haura E, Coppola D and Chellappan S: Nicotine promotes tumor growth
and metastasis in mouse models of lung cancer. PLoS One.
4:e75242009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Egleton RD, Brown KC and Dasgupta P:
Nicotinic acetylcholine receptors in cancer: Multiple roles in
proliferation and inhibition of apoptosis. Trends Pharmacol Sci.
29:151–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nguyen VT, Hall LL, Gallacher G, Ndoye A,
Jolkovsky DL, Webber RJ, Buchli R and Grando SA: Choline
acetyltransferase, acetylcholinesterase, and nicotinic
acetylcholine receptors of human gingival and esophageal epithelia.
J Dent Res. 79:939–949. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arredondo J, Chernyavsky AI, Jolkovsky DL,
Pinkerton KE and Grando SA: Receptor-mediated tobacco toxicity:
Cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways
downstream of alpha7 nicotinic receptor in oral keratinocytes.
FASEB J. 20:2093–2101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schuller HM: Is cancer triggered by
altered signalling of nicotinic acetylcholine receptors? Nat Rev
Cancer. 9:195–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishioka T, Guo J, Yamamoto D, Chen L,
Huppi P and Chen CY: Nicotine, through upregulating pro-survival
signaling, cooperates with NNK to promote transformation. J Cell
Biochem. 109:152–161. 2010.
|
|
20
|
Guo J, Ibaragi S, Zhu T, Luo LY, Hu GF,
Huppi PS and Chen CY: Nicotine promotes mammary tumor migration via
a signaling cascade involving protein kinase C and CDC42. Cancer
Res. 68:8473–8481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye YN, Liu ESL, Shin VY, Wu WKK, Luo JC
and Cho CH: Nicotine promoted colon cancer growth via epidermal
growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal
pathway. J Pharmacol Exp Ther. 308:66–72. 2004. View Article : Google Scholar
|
|
22
|
Nishioka T, Kim HS, Luo LY, Huang Y, Guo J
and Chen CY: Sensitization of epithelial growth factor receptors by
nicotine exposure to promote breast cancer cell growth. Breast
Cancer Res. 13:R1132011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Li H, Takayama S, Harada K, Okamoto
T, Iwama I, Fujii E, Ota A, Hidaka K, Kawano NY, et al: Nicotine
induces resistance to erlotinib via cross-talk between α 1 nAChR
and EGFR in the non-small cell lung cancer xenograft model. Lung
Cancer. 88:1–8. 2015. View Article : Google Scholar
|
|
24
|
Wang S, Takayama K, Tanaka K, Takeshita M,
Nakagaki N, Ijichi K, Li H and Nakanishi Y: Nicotine induces
resistance to epidermal growth factor receptor tyrosine kinase
inhibitor by α1 nicotinic acetylcholine receptor-mediated
activation in PC9 cells. J Thorac Oncol. 8:719–725. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao W, Yan J, Gao L, Zhao J, Zhao C, Gao
C, Luo X and Zhu X: Cdk5 is required for the neuroprotective effect
of transforming growth factor-β1 against cerebral
ischemia-reperfusion. Biochem Biophys Res Commun. 485:775–781.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang S, Deng Z, Yao C, Huang P, Zhang Y,
Cao S and Li X: AT7867 Inhibits human colorectal cancer cells via
AKT-dependent and AKT-independent mechanisms. PLoS One.
12:e01695852017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
von Roemeling CA, Marlow LA, Kennedy WP,
Kennedy GT, Copland JA and Menefee ME: Preclinical evaluation of
the mTOR inhibitor, temsirolimus, in combination with the
epothilone B analog, ixabepilone in renal cell carcinoma. Am J
Cancer Res. 3:390–401. 2013.PubMed/NCBI
|
|
28
|
Minna JD: Nicotine exposure and bronchial
epithelial cell nicotinic acetylcholine receptor expression in the
pathogenesis of lung cancer. J Clin Invest. 111:31–33. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heusch WL and Maneckjee R: Signalling
pathways involved in nicotine regulation of apoptosis of human lung
cancer cells. Carcinogenesis. 19:551–556. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kurai J, Chikumi H, Hashimoto K, Takata M,
Sako T, Yamaguchi K, Kinoshita N, Watanabe M, Touge H, Makino H, et
al: Therapeutic antitumor efficacy of anti-epidermal growth factor
receptor antibody, cetuximab, against malignant pleural
mesothelioma. Int J Oncol. 41:1610–1618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takada H, Ibaragi S, Eguchi T, Okui T,
Obata K, Masui M, Morisawa A, Takabatake K, Kawai H, Yoshioka N, et
al: Semaphorin 4D promotes bone invasion in head and neck squamous
cell carcinoma. Int J Oncol. 51:625–632. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Harrell MI, Iritani BM and Ruddell A:
Tumor-induced sentinel lymph node lymphangiogenesis and increased
lymph flow precede melanoma metastasis. Am J Pathol. 170:774–786.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bagdas D, Meade JA, Alkhlaif Y, Muldoon
PP, Carroll FI and Damaj MI: Effect of nicotine and alpha-7
nicotinic modulators on visceral pain-induced conditioned place
aversion in mice. Eur J Pain. Apr 10–2018.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wild R, Fager K, Flefleh C, Kan D, Inigo
I, Castaneda S, Luo FR, Camuso A, McGlinchey K and Rose WC:
Cetuximab preclinical antitumor activity (monotherapy and
combination based) is not predicted by relative total or activated
epidermal growth factor receptor tumor expression levels. Mol
Cancer Ther. 5:104–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shibata T, Kan H, Murakami Y, Ureshino H,
Watari K, Kawahara A, Kage M, Hattori S, Ono M and Kuwano M: Y-box
binding protein-1 contributes to both HER2/ErbB2 expression and
lapatinib sensitivity in human gastric cancer cells. Mol Cancer
Ther. 12:737–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matsui T, Ota T, Ueda Y, Tanino M and
Odashima S: Isolation of a highly metastatic cell line to lymph
node in human oral squamous cell carcinoma by orthotopic
implantation in nude mice. Oral Oncol. 34:253–256. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chikamatsu K, Reichert TE, Kashii Y, Saito
T, Kawashiri S, Yamamoto E and Whiteside TL: Immunotherapy with
effector cells and IL-2 of lymph node metastases of human
squamous-cell carcinoma of the head and neck established in nude
mice. Int J Cancer. 82:532–537. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nickell JR, Grinevich VP, Siripurapu KB,
Smith AM and Dwoskin LP: Potential therapeutic uses of mecamylamine
and its stereoisomers. Pharmacol Biochem Behav. 108:28–43. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shytle RD, Penny E, Silver AA, Goldman J
and Sanberg PR: Mecamylamine (Inversine): An old antihypertensive
with new research directions. J Hum Hypertens. 16:453–457. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Young HS, Herbette LG and Skita V:
α-bungarotoxin binding to acetylcholine receptor membranes studied
by low angle X-ray diffraction. Biophys J. 85:943–953. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dasgupta P, Rizwani W, Pillai S, Kinkade
R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, et
al: Nicotine induces cell proliferation, invasion and
epithelial-mesenchymal transition in a variety of human cancer cell
lines. Int J Cancer. 124:36–45. 2009. View Article : Google Scholar
|
|
42
|
Wang C, Niu W, Chen H, Shi N, He D, Zhang
M, Ge L, Tian Z, Qi M, Chen T, et al: Nicotine suppresses apoptosis
by regulating α7nAChR/Prx1 axis in oral precancerous lesions.
Oncotarget. 8:75065–75075. 2017.PubMed/NCBI
|
|
43
|
Arredondo J, Chernyavsky AI and Grando SA:
Nicotinic receptors mediate tumorigenic action of tobacco-derived
nitrosamines on immortalized oral epithelial cells. Cancer Biol
Ther. 5:511–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fujiwara T, Eguchi T, Sogawa C, Ono K,
Murakami J, Ibaragi S, Asaumi JI, Okamoto K, Calderwood SK and
Kozaki KI: Anti-EGFR antibody cetuximab is secreted by oral
squamous cell carcinoma and alters EGF-driven mesenchymal
transition. Biochem Biophys Res Commun. 503:1267–1272. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ono K, Eguchi T, Sogawa C, Calderwood SK,
Futagawa J, Kasai T, Seno M, Okamoto K, Sasaki A and Kozaki KI:
HSP-enriched properties of extracellular vesicles involve survival
of metastatic oral cancer cells. J Cell Biochem. 119:7350–7362.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Togashi Y, Hayashi H, Okamoto K, Fumita S,
Terashima M, de Velasco MA, Sakai K, Fujita Y, Tomida S, Nakagawa
K, et al: Chronic nicotine exposure mediates resistance to EGFR-TKI
in EGFR-mutated lung cancer via an EGFR signal. Lung Cancer.
88:16–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kajizono M, Saito M, Maeda M, Yamaji K,
Fujiwara S, Kawasaki Y, Matsunaga H and Sendo T: Cetuximab-induced
skin reactions are suppressed by cigarette smoking in patients with
advanced colorectal cancer. Int J Clin Oncol. 18:684–688. 2013.
View Article : Google Scholar
|
|
48
|
Xu J, Huang H, Pan C, Zhang B, Liu X and
Zhang L: Nicotine inhibits apoptosis induced by cisplatin in human
oral cancer cells. Int J Oral Maxillofac Surg. 36:739–744. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Weller MA, Ward MC, Berriochoa C, Reddy
CA, Trosman S, Greskovich JF, Nwizu TI, Burkey BB, Adelstein DJ and
Koyfman SA: Predictors of distant metastasis in human
papillomavirus-associated oropharyngeal cancer. Head Neck.
39:940–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
